These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29570673)

  • 1. Protective Effects of Gomisin N against Hepatic Cannabinoid Type 1 Receptor-Induced Insulin Resistance and Gluconeogenesis.
    Nagappan A; Jung DY; Kim JH; Jung MH
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of gomisin N against hepatic steatosis through AMPK activation.
    Yun YR; Kim JH; Kim JH; Jung MH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1095-1101. PubMed ID: 27914812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gomisin N Alleviates Ethanol-Induced Liver Injury through Ameliorating Lipid Metabolism and Oxidative Stress.
    Nagappan A; Jung DY; Kim JH; Lee H; Jung MH
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
    Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
    J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis.
    Jang MK; Yun YR; Kim SH; Kim JH; Jung MH
    Biol Pharm Bull; 2016 May; 39(5):832-8. PubMed ID: 26860972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene.
    Chanda D; Kim YH; Kim DK; Lee MW; Lee SY; Park TS; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2012 Nov; 287(45):38041-9. PubMed ID: 22989885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic effect of gomisin N via activation of AMP-activated protein kinase.
    Jung DY; Kim JH; Lee H; Jung MH
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):587-593. PubMed ID: 29079190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Characterization of Gomisin N in High-Fat-Induced
    Lee JY; Lee JH; Cheon CK
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gomisin J Inhibits Oleic Acid-Induced Hepatic Lipogenesis by Activation of the AMPK-Dependent Pathway and Inhibition of the Hepatokine Fetuin-A in HepG2 Cells.
    Kim M; Lim SJ; Lee HJ; Kim SY; Nho CW
    J Agric Food Chem; 2015 Nov; 63(44):9729-39. PubMed ID: 26455261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress.
    Jang MK; Nam JS; Kim JH; Yun YR; Han CW; Kim BJ; Jeong HS; Ha KT; Jung MH
    J Ethnopharmacol; 2016 Jun; 185():96-104. PubMed ID: 26972505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
    Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
    Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.
    Liu J; Zhou L; Xiong K; Godlewski G; Mukhopadhyay B; Tam J; Yin S; Gao P; Shan X; Pickel J; Bataller R; O'Hare J; Scherer T; Buettner C; Kunos G
    Gastroenterology; 2012 May; 142(5):1218-1228.e1. PubMed ID: 22307032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protectin DX suppresses hepatic gluconeogenesis through AMPK-HO-1-mediated inhibition of ER stress.
    Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
    Cell Signal; 2017 Jun; 34():133-140. PubMed ID: 28342842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.
    Jang MK; Han YR; Nam JS; Han CW; Kim BJ; Jeong HS; Ha KT; Jung MH
    Int J Mol Sci; 2015 Nov; 16(11):26151-65. PubMed ID: 26540043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troxerutin Attenuates Enhancement of Hepatic Gluconeogenesis by Inhibiting NOD Activation-Mediated Inflammation in High-Fat Diet-Treated Mice.
    Zhang Z; Wang X; Zheng G; Shan Q; Lu J; Fan S; Sun C; Wu D; Zhang C; Su W; Sui J; Zheng Y
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes.
    Shi CX; Zhao MX; Shu XD; Xiong XQ; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Sci Rep; 2016 Feb; 6():21924. PubMed ID: 26907958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
    Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
    Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
    Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
    Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.